Synthesis of Ethylphosphonate Curcumin Mimics: Substituents Allow Switching Between Cytotoxic and Cytoprotective Activities
Curcumin is recognized for its diverse biological activities, including the ability to induce apoptosis and ferroptosis. Therefore, it represents a promising candidate for the development of new compounds with neuroprotective and anticancer properties. In order to synthesize mimics with improved pharmacokinetic properties (better solubility and stability than curcumin) here, we present the design and synthesis of novel curcumin analogues named Ethylphosphonate-based curcumin mimics (EPs), which preserve the pharmacophoric features of curcumin. New EP mimics were synthesized by tyrosol- and melatonin-based building blocks using an orthogonal protection approach of the different precursors' OH functions with good yields and in a few steps. Comparative screenings of the cytotoxic and cytoprotective properties (curcumin was used as a reference compound) were carried out on all new mimics in different cell lines (HeLa, A375, WM266, MDA-MB-231, LX2, and HDF). Assays with inhibitors of ferroptosis (Ferrostatin-1, Fer-1) and apoptosis (Quinoline-Val-Asp-difluorophenoxymethyl ketone, Q-VD), in combination with curcumin, suggested the specific cell death pathway (apoptotic or ferroptotic) of EPs, depending on the aromatic moieties contained in them. Interestingly, <b>EP4</b> exhibited substantial cytotoxic effects against various human cancer cell lines (HeLa, A375, WM266) while sparing normal cells (HDFs). <b>EP4</b> displayed a five-times-higher toxicity in triple-negative MDA-MB-231 and LX2 stellate cells than curcumin. The cytotoxicity exerted by <b>EP4</b> involves only an apoptotic mechanism, contrary to curcumin, which exerts both apoptotic and ferroptotic effects. Additionally, <b>EP4</b> was also found to be a very potent inhibitor of the ubiquitin-activating enzyme E1, reinforcing the anticancer potential of this compound. Furthermore, <b>EP2</b> possesses high antioxidant properties, efficiently protects against cell death by ferroptosis, and inhibits the amyloid aggregation involved in AD.
Authors
- Danilo Milardi (ORCID: https://orcid.org/0000-0003-3940-9439)
- Domenica Capasso (ORCID: https://orcid.org/0000-0001-7201-3431)
- Minh Bui Hoang (ORCID: https://orcid.org/0009-0009-4454-2956)
- Solveigh C. Koeberle (ORCID: https://orcid.org/0000-0002-8008-494X)
- Giovanni Di Fabio (ORCID: https://orcid.org/0000-0003-2912-4827)
- Andreas Koeberle (ORCID: https://orcid.org/0000-0001-6269-5088)
- Valeria Romanucci (ORCID: https://orcid.org/0000-0003-0317-5140)
- Carmelo Tempra (ORCID: https://orcid.org/0000-0002-2890-6993)
- Rita Pagano (ORCID: https://orcid.org/0000-0002-9402-389X)
- Fabio Lolicato (ORCID: https://orcid.org/0000-0001-7537-0549)
- Michele F. M. Sciacca (ORCID: https://orcid.org/0000-0002-9981-3321)
- Valeria Lanza (ORCID: https://orcid.org/0000-0002-4529-807X)
- Armando Zarrelli (ORCID: https://orcid.org/0000-0001-7866-821X)
- Sonia Di Gaetano (ORCID: https://orcid.org/0000-0001-5523-3619)
Institutions
- University of Helsinki (FI)
- University of Graz (AT)
- Universität Innsbruck (AT)
- Heidelberg University (DE)
- Institute of Biostructure and Bioimaging (IT)
- Czech Academy of Sciences, Institute of Organic Chemistry and Biochemistry (CZ)
- National Research Council (IT)
- Institute of Crystallography (IT)
- University of Naples Federico II (IT)
Publication Details
- Journal
- Antioxidants
- Published
- 2025-03-29
- DOI
- https://doi.org/10.3390/antiox14040412
- Primary Topic
- Curcumin's Biomedical Applications
- Type
- article
- Field-Weighted Citation Impact
- 0.00